A 0 1 0 1 O
minimum 2 9 2 9 O
of 10 12 10 12 O
4 13 14 13 14 B-lower_bound
of 15 17 15 17 O
11 18 20 18 20 B-upper_bound
current 21 28 21 28 O
alcohol 29 36 29 36 O
use 37 40 37 40 O
disorder 41 49 41 49 O
symptoms 50 58 50 58 O
by 59 61 59 61 O
DSM-5 62 67 62 67 O

Acute 0 5 68 73 B-chronic_disease
narrow 6 12 74 80 I-chronic_disease
- 12 13 80 81 I-chronic_disease
angle 13 18 81 86 I-chronic_disease
glaucoma 19 27 87 95 I-chronic_disease

Current 0 7 96 103 O
dementia 8 16 104 112 B-chronic_disease

Current 0 7 113 120 O
major 8 13 121 126 B-chronic_disease
depressive 14 24 127 137 I-chronic_disease
disorder 25 33 138 146 I-chronic_disease
without 34 41 147 154 O
psychotic 42 51 155 164 O
features 52 60 165 173 O
by 61 63 174 176 O
DSM-5 64 69 177 182 O
( 70 71 183 184 O
antidepressant 71 85 184 198 B-treatment
regimens 86 94 199 207 O
can 95 98 208 211 O
be 99 101 212 214 O
allowed 102 109 215 222 O
and 110 113 223 226 O
changed 114 121 227 234 O
during 122 128 235 241 O
the 129 132 242 245 O
trial 133 138 246 251 O
) 138 139 251 252 O

Current 0 7 253 260 O
or 8 10 261 263 O
past 11 15 264 268 O
history 16 23 269 276 O
of 24 26 277 279 O
psychotic 27 36 280 289 B-chronic_disease
features 37 45 290 298 I-chronic_disease
or 46 48 299 301 I-chronic_disease
psychotic 49 58 302 311 I-chronic_disease
disorder 59 67 312 320 I-chronic_disease

Current 0 7 321 328 O
substance 8 17 329 338 B-chronic_disease
use 18 21 339 342 I-chronic_disease
disorder 22 30 343 351 I-chronic_disease
by 31 33 352 354 O
DSM-5 34 39 355 360 O
in 40 42 361 363 O
the 43 46 364 367 O
past 47 51 368 372 B-upper_bound
3 52 53 373 374 I-upper_bound
months 54 60 375 381 I-upper_bound
( 61 62 382 383 O
except 62 68 383 389 O
alcohol 69 76 390 397 O
, 76 77 397 398 O
tobacco 78 85 399 406 O
, 85 86 406 407 O
or 87 89 408 410 O
cannabis 90 98 411 419 O
) 98 99 419 420 O

Current 0 7 421 428 O
uncontrolled 8 20 429 441 B-chronic_disease
hypertension 21 33 442 454 I-chronic_disease
( 34 35 455 456 O
systolic 35 43 456 464 B-clinical_variable
BP 44 46 465 467 I-clinical_variable
> 47 48 468 469 O
170 49 52 470 473 B-lower_bound
mm 53 55 474 476 I-lower_bound
Hg 56 58 477 479 I-lower_bound
or 59 61 480 482 O
diastolic 62 71 483 492 B-clinical_variable
BP 72 74 493 495 I-clinical_variable
> 75 76 496 497 O
100 77 80 498 501 B-lower_bound
mm 81 83 502 504 I-lower_bound
Hg 84 86 505 507 I-lower_bound
) 86 87 507 508 O

Current 0 7 509 516 O
use 8 11 517 520 O
of 12 14 521 523 O
benzodiazepine 15 29 524 538 B-treatment

Heavy 0 5 539 544 O
drinking 6 14 545 553 O
at 15 17 554 556 O
least 18 23 557 562 O
4 24 25 563 564 B-lower_bound
times 26 31 565 570 I-lower_bound
in 32 34 571 573 I-lower_bound
the 35 38 574 577 I-lower_bound
past 39 43 578 582 I-lower_bound
month 44 49 583 588 I-lower_bound
( 50 51 589 590 O
' 51 52 590 591 O
heavy 52 57 591 596 O
drinking 58 66 597 605 O
' 66 67 605 606 O
defined 68 75 607 614 O
as 76 78 615 617 O
5 79 80 618 619 O
standard 81 89 620 628 O
drinks 90 96 629 635 O
per 97 100 636 639 O
day 101 104 640 643 O
for 105 108 644 647 O
men 109 112 648 651 B-gender
and 113 116 652 655 O
4 117 118 656 657 O
standard 119 127 658 666 O
drinks 128 134 667 673 O
per 135 138 674 677 O
day 139 142 678 681 O
for 143 146 682 685 O
women 147 152 686 691 B-gender

Imminent 0 8 692 700 O
suicidal 9 17 701 709 B-chronic_disease
or 18 20 710 712 O
homicidal 21 30 713 722 B-chronic_disease
risk 31 35 723 727 O

Montgomery 0 10 728 738 B-clinical_variable
- 10 11 738 739 I-clinical_variable
Asberg 11 17 739 745 I-clinical_variable
Depression 18 28 746 756 I-clinical_variable
Rating 29 35 757 763 I-clinical_variable
Scale 36 41 764 769 I-clinical_variable
( 42 43 770 771 I-clinical_variable
MADRS 43 48 771 776 I-clinical_variable
) 48 49 776 777 I-clinical_variable
20 50 52 778 780 B-lower_bound
or 53 55 781 783 O
higher 56 62 784 790 O

Opioid 0 6 791 797 B-treatment
use 7 10 798 801 O
within 11 17 802 808 O
10 18 20 809 811 B-upper_bound
days 21 25 812 816 I-upper_bound
prior 26 31 817 822 I-upper_bound
to 32 34 823 825 O
study 35 40 826 831 O
medication 41 51 832 842 O
( 52 53 843 844 O
injectable 53 63 844 854 B-treatment
naltrexone 64 74 855 865 I-treatment
) 74 75 865 866 O
or 76 78 867 869 O
risks 79 84 870 875 O
for 85 88 876 879 O
opioid 89 95 880 886 B-treatment
use 96 99 887 890 O
during 100 106 891 897 O
the 107 110 898 901 O
study 111 116 902 907 O

Pregnant 0 8 908 916 B-pregnancy

Severe 0 6 917 923 B-chronic_disease
sleep 7 12 924 929 I-chronic_disease
apnea 13 18 930 935 I-chronic_disease
--- 18 21 935 938 O
clinically 21 31 938 948 O
determined 32 42 949 959 O
by 43 45 960 962 O
a 46 47 963 964 O
physician 48 57 965 974 O

Unstable 0 8 975 983 O
medical 9 16 984 991 O
condition 17 26 992 1001 O
or 27 29 1002 1004 O
allergy 30 37 1005 1012 O
to 38 40 1013 1015 O
ketamine 41 49 1016 1024 B-allergy_name
, 49 50 1024 1025 O
midazolam 51 60 1026 1035 B-allergy_name
, 60 61 1035 1036 O
naltrexone 62 72 1037 1047 B-allergy_name
, 72 73 1047 1048 O
or 74 76 1049 1051 O
lorazepam 77 86 1052 1061 B-allergy_name
--- 86 89 1061 1064 O
clinically 89 99 1064 1074 O
determined 100 110 1075 1085 O
by 111 113 1086 1088 O
a 114 115 1089 1090 O
physician 116 125 1091 1100 O

nursing 0 7 1101 1108 O
women 8 13 1109 1114 B-gender

positive 0 8 1115 1123 B-pregnancy
pregnancy 9 18 1124 1133 I-pregnancy
test 19 23 1134 1138 O
, 23 24 1138 1139 O
or 25 27 1140 1142 O
inadequate 28 38 1143 1153 O
birth 39 44 1154 1159 O
control 45 52 1160 1167 O
methods 53 60 1168 1175 O
in 61 63 1176 1178 O
women 64 69 1179 1184 B-gender
of 70 72 1185 1187 O
childbearing 73 85 1188 1200 O
potential 86 95 1201 1210 O

